ANNX
Price
$4.51
Change
+$0.24 (+5.62%)
Updated
Nov 24 closing price
Capitalization
671.5M
104 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$0.98
Change
-$0.01 (-1.01%)
Updated
Nov 25, 10:46 AM (EDT)
Capitalization
56.19M
106 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANNX vs TCRX

Header iconANNX vs TCRX Comparison
Open Charts ANNX vs TCRXBanner chart's image
Annexon
Price$4.51
Change+$0.24 (+5.62%)
Volume$3.84M
Capitalization671.5M
TScan Therapeutics
Price$0.98
Change-$0.01 (-1.01%)
Volume$170
Capitalization56.19M
ANNX vs TCRX Comparison Chart in %
ANNX
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANNX vs. TCRX commentary
Nov 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a StrongBuy and TCRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (ANNX: $4.51 vs. TCRX: $0.99)
Brand notoriety: ANNX and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 153% vs. TCRX: 87%
Market capitalization -- ANNX: $671.5M vs. TCRX: $56.19M
ANNX [@Biotechnology] is valued at $671.5M. TCRX’s [@Biotechnology] market capitalization is $56.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ANNX is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 7 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • ANNX’s TA Score: 7 bullish, 4 bearish.
  • TCRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than TCRX.

Price Growth

ANNX (@Biotechnology) experienced а +49.17% price change this week, while TCRX (@Biotechnology) price change was +2.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.07%. For the same industry, the average monthly price growth was -3.19%, and the average quarterly price growth was +68.21%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 09, 2026.

TCRX is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+1.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANNX($671M) has a higher market cap than TCRX($56.2M). ANNX YTD gains are higher at: -12.183 vs. TCRX (-67.428). TCRX has higher annual earnings (EBITDA): -130.55M vs. ANNX (-198.44M). ANNX (227M) and TCRX (218M) have equal amount of cash in the bank . ANNX has less debt than TCRX: ANNX (27.6M) vs TCRX (96.7M). TCRX has higher revenues than ANNX: TCRX (6.96M) vs ANNX (0).
ANNXTCRXANNX / TCRX
Capitalization671M56.2M1,194%
EBITDA-198.44M-130.55M152%
Gain YTD-12.183-67.42818%
P/E RatioN/AN/A-
Revenue06.96M-
Total Cash227M218M104%
Total Debt27.6M96.7M29%
TECHNICAL ANALYSIS
Technical Analysis
ANNXTCRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLAKY9.310.12
+1.31%
Deutsche Lufthansa AG
UBAAF6.030.04
+0.63%
Urbana Corp.
AILLN79.00N/A
N/A
Ameren Illinois Company
MURSF0.03N/A
N/A
Murray & Roberts Holdings Ltd.
MAWHY12.08-0.75
-5.85%
Man Wah Holdings, Ltd.

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with NRIX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+5.50%
NRIX - ANNX
43%
Loosely correlated
+2.27%
AURA - ANNX
43%
Loosely correlated
+1.19%
IDYA - ANNX
43%
Loosely correlated
+2.00%
CRNX - ANNX
42%
Loosely correlated
+2.19%
ZYME - ANNX
42%
Loosely correlated
+4.00%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+2.85%
FATE - TCRX
40%
Loosely correlated
+5.34%
MGNX - TCRX
38%
Loosely correlated
+1.43%
ELVN - TCRX
37%
Loosely correlated
+0.05%
ZNTL - TCRX
37%
Loosely correlated
+4.10%
RGNX - TCRX
36%
Loosely correlated
+3.64%
More